Cite Filings / PRME / 0001628280-23-017423

Feed Companies Filings Check

Sign in

10-Q

Quarterly Report

Prime Medicine, Inc. Filed 2023-05-11 Acc 0001628280-23-017423

Documents 1

10-Q Quarterly Report , prme-20230331.htm

Around this filing

2023-08-07 10-Q Quarterly Report
2023-05-11 10-Q Quarterly Report
2023-05-11 DEFA14A Proxy Materials
2023-05-11 8-K Executive or director change
2023-05-11 8-K Results of operations
2023-05-10 4 10% owner sold 422,010 shares at an average $14.09 ($5,946,340)
2022-11-14 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading prme-20230331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…